INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR60m ago
SEC 13F60m ago
Robinhood Chain60m ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

18,675 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
38
NT
Notman TaliCHIEF REVENUE OFFICER
FROGJFrog Ltd
Open-market sale
SELL$1.73M
19.2K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
Page 121 of 467
← PrevNext →
+2d
SEC Form 4

Evidence

38
PA
Pollitzer AdamDirector, Chief Executive Officer
NMIHNMI Holdings, Inc.
Open-market sale
SELL$7.75M
172.7K sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

38
SA
Shauli AviChief Technology Officer
RSKDRISKIFIED LTD.
Open-market sale
SELL$193K
30.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

36
SC
Spice Adam C.Chief Financial Officer
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$4.19M
67.3K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

36
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$74K
2,800 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

36
CP
Courtney PhillipsGC and Corp. Secretary
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$6,590
243 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

36
SC
Spice Adam C.Chief Financial Officer
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$4.59M
72.9K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

36
MJ
Marquina JavierDirector
LPALogistic Properties of the Americas
Open-market sale
SELL$5,562
1,800 sh
Sep 1, 2026Sep 4, 2026
traded Sep 1, 2026
+3dSEC Form 4

Evidence

36
SJ
Simon JoshDirector, Chief Executive Officer
FNKOFunko, Inc.
Open-market sale
SELL$267K
45.5K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

36
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$83K
3,207 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

36
CV
Coloma Jason VDirector, Chief Executive Officer
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$37K
1,375 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

35
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$246K
78.1K sh
Aug 31, 2026Sep 4, 2026
traded Aug 31, 2026
+4dSEC Form 4

Evidence

35
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Open-market sale
SELL$2.95M
119.2K sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

34
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$769K
15.4K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

34
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$513K
10.2K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

34
VA
Viozzi Vincent AnthonySr. VP & Chief Inv Officer
DGICADONEGAL GROUP INC
Open-market sale
SELL$44K
2,282 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

34
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$547K
11.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

33
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$509K
2,265 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

33
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$516K
2,271 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

33
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$559K
2,500 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

32
BE
Bonanni Mark EmilioEVP, CRO, Commercial
OUTOUTFRONT Media Inc.
Open-market sale
SELL$101K
3,385 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

32
CV
Coloma Jason VDirector, Chief Executive Officer
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$3,325
129 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

32
CK
Cunningham Bradley KramerChief Technology Officer
PAYSPaysign, Inc.
Open-market sale
SELL$23K
3,000 sh
Jun 1, 2026Sep 4, 2026
traded Jun 1, 2026
+95dSEC Form 4

Evidence

32
CP
Courtney PhillipsGC and Corp. Secretary
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$567
22 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

31
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$112K
35.8K sh
Sep 1, 2026Sep 4, 2026
traded Sep 1, 2026
+3dSEC Form 4

Evidence

31
BG
Boyan GeorgeDirector, President
UNTYUNITY BANCORP INC /NJ/
Open-market sale
SELL$385K
6,504 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

31
QM
Quirk Steven M.Chief Brokerage Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$1.58M
13.2K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

31
MD
Moatazedi DavidDirector, See Remarks
EOLSEvolus, Inc.
Open-market sale
SELL$950K
105.1K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

30
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$291K
5,752 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

29
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$929
36 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

29
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$17K
625 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

29
SM
Schafer Douglas M. JREVP and CIO
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$1.94M
48.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

29
CJ
Comly Barbara J.EVP, GC & Corporate Secretary
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$1.80M
44.4K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

29
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$11K
391 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

29
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$1,521
59 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

28
CP
Carlin PeterDirector
ADNTAdient plc
Open-market sale
SELL$151K
7,843 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

27
CN
Caezza NicholasDeputy General Counsel
BFLYButterfly Network, Inc.
Open-market sale
SELL$14K
1,709 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

27
RA
Ravin Seth A.Director, President, CEO & Chairman, 10% Owner
RMNIRimini Street, Inc.
Open-market sale
SELL$992K
191.7K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

26
MJ
Marquina JavierDirector
LPALogistic Properties of the Americas
Open-market sale
SELL$5,421
1,760 sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

26
DE
Deitzel EdwardEVP, CRO, CCO MIAX Exchanges
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$464K
11.0K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K